New funding will help Gavi, the Vaccine Alliance, vaccinate millions of children against deadly diseases.

Abu Dhabi, 10 December 2018 - Children across Africa and Asia will be protected against some of the world’s deadliest diseases thanks to a new $15 million pledge to Gavi, the Vaccine Alliance by the Republic of Korea.

The new funding, announced today at Gavi’s mid-term review in Abu Dhabi, will be delivered over three years from 2019-2021 and will be funded through Korea’s Global Disease Eradication Fund. South Korea became the first East Asian donor to Gavi in 2010, and has since provided $19 million to the Vaccine Alliance.

“Korea was the first East Asian nation to lend its support to Gavi and it has now been a steadfast supporter of our mission to ensure no child goes without lifesaving vaccines for nearly a decade,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “This new funding will help vaccinate millions of children against some of the world’s deadliest diseases. I’d like to offer my sincere thanks on behalf of Gavi to the government and people of Korea for this support.”

“I am very proud of the remarkable progress and achievements made by the Alliance,” said Kyung-ah Lee, Deputy Director-General of the Development Cooperation Bureau, Ministry of Foreign Affairs (MOFA). “As a longstanding donor to Gavi, the Republic of Korea will continue to support the Alliance and actively take part in global partnerships for health security. And let us build the strongest Alliance ever together to achieve the SDGs by delivering immunisation and saving lives.”

Korea’s contribution will support Gavi’s work protecting children in 68 of the world’s poorest countries in Africa and Asia against some of the world’s leading killers of children, like pneumonia, diarrhoea and measles. Since its inception in 2000, Gavi has immunised over 700 million children, saving 10 million lives.

As well as financial support, Korean vaccine manufacturers are also having a major impact on the health of children in the developing world. EuBiologics, for example, based in Gangwon-do now produces the majority of the Gavi-funded global cholera vaccine stockpile, which has recently been used to tackle outbreaks in countries from Yemen to Bangladesh to Nigeria.

Gavi’s mid-term review, held in Abu Dhabi, United Arab Emirates (UAE) on 10-11 December, is a high-level conference celebrating Gavi’s progress and impact in the world’s poorest countries. By the end of 2018, Gavi will have contributed to the immunisation of 700 million people and the prevention of more than 10 million future deaths. This has contributed to an acceleration in the decline of global under-five mortality rates and brought wider impact beyond immunisation.

As well as reviewing progress made since the last Gavi replenishment in Berlin in 2015, this high-level conference is also an opportunity to shape Gavi’s future and help overcome the challenges preventing children from receiving the full course of recommended vaccines. Immunisation is a cost effective and high impact intervention that is core to primary health care and provides a robust platform to deliver better health for all.


Gavi, the Vaccine Alliance is supported by donor governments (Australia, Brazil, Canada, Denmark, France, Germany, India, Ireland, Italy, Japan, the Kingdom of Saudi Arabia, Luxembourg, the Netherlands, Norway, the People’s Republic of China, Principality of Monaco, Republic of Korea, Russia, South Africa, Spain, the State of Qatar, the Sultanate of Oman, Sweden, Switzerland, United Kingdom, and United States), the European Commission, Alwaleed Philanthropies, the OPEC Fund for International Development (OFID), the Bill & Melinda Gates Foundation, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, as well as private and corporate partners (Absolute Return for Kids, Anglo American plc., The Audacious Project, The Children’s Investment Fund Foundation, China Merchants Group, Comic Relief, Deutsche Post DHL, the ELMA Vaccines and Immunization Foundation, Girl Effect, The International Federation of Pharmaceutical Wholesalers (IFPW), the Gulf Youth Alliance, JP Morgan, “la Caixa” Foundation, LDS Charities, Lions Clubs International Foundation, Majid Al Futtaim, Orange, Philips, Reckitt Benckiser, Unilever, UPS and Vodafone).

For more information click here.

Media contacts

Iryna Mazur

Iryna Mazur

+41 22 909 2920

Frédérique Tissandier

Frédérique Tissandier
+41 79 300 8253
+41 22 909 2968

Subscribe to our newsletter